Fetal cell microchimerism and susceptibility to COVID-19 disease in women.
COVID-19
Fetal cell microchimerism
Microchimeric cells
Pregnancy
SARS-CoV-2
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
21
11
2022
accepted:
14
02
2023
medline:
19
7
2023
pubmed:
2
3
2023
entrez:
1
3
2023
Statut:
ppublish
Résumé
The clinical outcome of COVID-19 disease is worse in males, and the reasons of this gender disparity are currently unclear, though evidences point to a combination of biological and gender-specific factors. A phenomenon unique to the female gender is the fetal cell microchimerism (FCM), defined as the presence of fetal microchimeric cells in maternal organs and in the circulation for years after delivery and usually evaluated by assessing the presence of male cells or DNA in a woman. In the present case-control study, we aimed to evaluate the possible effect of pregnancy and related FCM on the susceptibility to SARS-CoV-2 infection and on the clinical course and outcome of COVID-19. One hundred twenty-three women with a previous male pregnancy, comprising 63 COVID-19 cases and 60 healthy controls were enrolled. The presence of blood male DNA was assessed by the amplification of the Y-chromosome specific gene SRY. The prevalence of male DNA of presumed fetal origin was significantly higher in healthy controls than in COVID-19 cases (70 vs 44.4%, P = 0.0044; OR 0.3429, 95% CI 0.1631-0.7207, P = 0.0047). Among women affected with COVID-19, the presence of male FCM did not significantly influence the severity of the disease, though the 8 deceased women studied were all FCM negative. This is the first case-control study reporting the prevalence of FCM in COVID-19 and healthy women. Overall, our data seem to suggest a role for FCM in the protection towards the SARS-CoV-2 infection with a possible positive impact on clinical outcome.
Identifiants
pubmed: 36857020
doi: 10.1007/s15010-023-02006-x
pii: 10.1007/s15010-023-02006-x
pmc: PMC9975871
doi:
Substances chimiques
DNA
9007-49-2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1071-1078Subventions
Organisme : Italian Ministry of Health
ID : COVENDO 05C21 CORR2020
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. The Author(s).
Références
Wortham JM, Lee JT, Althomsons S, Latash J, Davidson A, Guerra K, et al. Characteristics of persons who died with COVID-19 - United States, february 12-May 18, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:923–9.
doi: 10.15585/mmwr.mm6928e1
pubmed: 32673298
Istituto Superiore di Sanità. Bollettino-sorveglianza-integrata-COVID-19 26 marzo 2020. Epidemia COVID-19 Aggiornamento nazionale 26 marzo 2020. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/ %25202020.pdf+&cd=2&hl=it&ct=clnk&gl=it.
Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92:577–83.
doi: 10.1002/jmv.25757
pubmed: 32162702
pmcid: 7228329
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region. Italy JAMA. 2020;323:1574–81.
doi: 10.1001/jama.2020.5394
pubmed: 32250385
Ambrosino I, Barbagelata E, Ortona E, Ruggieri A, Massiah G, Giannico OV, et al. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020;90.
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in patients With COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.
doi: 10.3389/fpubh.2020.00152
pubmed: 32411652
pmcid: 7201103
Lai CC, Wang JH, Hsueh PR. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review. Int J Infect Dis. 2020;101:314–22.
doi: 10.1016/j.ijid.2020.10.011
pubmed: 33045429
pmcid: 7546669
Istituto Nazionale di Statistica. Impatto dell’epidemia COVID-19 sulla mortalità totale della popolazione residente. Anno 20220 e Gennaio-Aprile 2021. Available from: https://www.istat.it/it/files//2021/06/Report_ISS_Istat_2021_10_giugno.pdf .
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:29.
doi: 10.1186/s13293-020-00304-9
pubmed: 32450906
pmcid: 7247289
Casari S, Lucchini G, Burato E, Bertoletti R, Boscaini R, Bellani A, et al. Epidemia di COVID-19: l’esperienza della struttura socio sanitaria territoriale provinciale di mantova [The COVID-19 epidemic: the experience in the social and health care center of the mantua district (Lombardy Region, Northern Italy)]. Epidemiol Prev. 2021;45:559–67.
pubmed: 35001599
Fidecicchi T, Fruzzetti F, Lete Lasa LI, Calaf J. COVID-19, gender and estroprogestins, what do we know? Eur J Contracept Reprod Health Care. 2022;27:67–74.
doi: 10.1080/13625187.2021.2000959
pubmed: 34842025
Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? Int J Mol Sci. 2020;21:3474.
doi: 10.3390/ijms21103474
pubmed: 32423094
pmcid: 7278991
Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol. 2021;16:38–47.
doi: 10.1007/s11481-020-09974-z
pubmed: 33405098
pmcid: 7786186
Forsyth KS, Anguera MC. Time to get ill: the intersection of viral infections, sex, and the X chromosome. Curr Opin Physiol. 2021;19:62–72.
doi: 10.1016/j.cophys.2020.09.015
pubmed: 33073073
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93:705–8.
doi: 10.1073/pnas.93.2.705
pubmed: 8570620
pmcid: 40117
O’Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179–82.
doi: 10.1016/S0140-6736(04)16631-2
pubmed: 15246731
Fugazzola L, Cirello V, Beck-Peccoz P. Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol. 2011;7:89–97.
doi: 10.1038/nrendo.2010.216
pubmed: 21178998
Fugazzola L, Cirello V, Beck-Peccoz P. Microchimerism and endocrine disorders. J Clin Endocrinol Metab. 2012;97:1452–61.
doi: 10.1210/jc.2011-3160
pubmed: 22399520
Cirello V, Perrino M, Colombo C, Muzza M, Filopanti M, Vicentini L, et al. Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues. Int J Cancer. 2010;126:2874–8.
pubmed: 19856309
Cirello V, Rizzo R, Crippa M, Campi I, Bortolotti D, Bolzani S, et al. Fetal cell microchimerism: a protective role in autoimmune thyroid diseases. Eur J Endocrinol. 2015;173:111–8.
doi: 10.1530/EJE-15-0028
pubmed: 25916393
Cirello V, Colombo C, Perrino M, De Leo S, Muzza M, Maffini MA, et al. Fetal cell microchimerism in papillary thyroid cancer: a role in the outcome of the disease. Int J Cancer. 2015;137:2989–93.
doi: 10.1002/ijc.29653
pubmed: 26105768
Cirello V, Recalcati MP, Muzza M, Rossi S, Perrino M, Vicentini L, et al. Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res. 2008;68:8482–8.
doi: 10.1158/0008-5472.CAN-08-0672
pubmed: 18922922
Johnson KL, Samura O, Nelson JL, McDonnel WM, Bianchi DW. Significant fetal cell microchimerism in a nontransfused women with hepatitis C: evidence of long-term survival and expansion. Hepatology. 2002;36:1295–7.
doi: 10.1053/jhep.2002.35622
pubmed: 12395344
Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20:1742.
doi: 10.1186/s12889-020-09826-8
pubmed: 33213391
pmcid: 7675386
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–38.
doi: 10.1038/nri.2016.90
pubmed: 27546235
Jonsson AM, Papadogiannakis N, Granath A, Haggstrom J, Schaffer M, Uzunel M, et al. Maternal microchimerism in juvenile tonsils and adenoids. Pediatr Res. 2010;68:199–204.
doi: 10.1203/PDR.0b013e3181eb2eb4
pubmed: 20531252
Khosrotehrani K, Johnson KL, Guégan S, Stroh H, Bianchi DW. Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol. 2005;66:1–12.
doi: 10.1016/j.jri.2005.02.001
pubmed: 15949558
Rijnink EC, Penning ME, Wolterbeek R, Wilhelmus S, Zandbergen M, van Duinen SG, et al. Tissue microchimerism is increased during pregnancy: a human autopsy study. Mol Hum Reprod. 2015;21:857–64.
doi: 10.1093/molehr/gav047
pubmed: 26307194
Koopmans M, Kremer Hovinga IC, Baelde HJ, Harvey MS, de Heer E, Bruijn JA, et al. Chimerism occurs in thyroid, lung, skin and lymph nodes of women with sons. J Reprod Immunol. 2008;78:68–75.
doi: 10.1016/j.jri.2008.01.002
pubmed: 18329105
Fujiki Y, Johnson KL, Tighiouart H, Peter I, Bianchi DW. Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod. 2008;79:841–8.
doi: 10.1095/biolreprod.108.068973
pubmed: 18633138
pmcid: 2714997
Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci. 2005;118:1559–63.
doi: 10.1242/jcs.02332
pubmed: 15811948
Fujiki Y, Johnson KL, Peter I, Tighiouart H, Bianchi DW. Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers. Biol Reprod. 2009;81:26–32.
doi: 10.1095/biolreprod.108.074468
pubmed: 19279322
pmcid: 3093984
Pritchard S, Hoffman AM, Johnson KL, Bianchi DW. Pregnancy-associated progenitor cells: an under-recognized potential source of stem cells in maternal lung. Placenta. 2011;32(Suppl 4):S298-303.
doi: 10.1016/j.placenta.2011.04.007
pubmed: 21546085